Cisen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Cisen Pharmaceutical has a total shareholder equity of CN¥5.9B and total debt of CN¥194.8M, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are CN¥7.6B and CN¥1.6B respectively. Cisen Pharmaceutical's EBIT is CN¥527.1M making its interest coverage ratio -6.2. It has cash and short-term investments of CN¥2.8B.
Key information
3.3%
Debt to equity ratio
CN¥194.79m
Debt
Interest coverage ratio | -6.2x |
Cash | CN¥2.79b |
Equity | CN¥5.94b |
Total liabilities | CN¥1.62b |
Total assets | CN¥7.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603367's short term assets (CN¥5.2B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 603367's short term assets (CN¥5.2B) exceed its long term liabilities (CN¥191.8M).
Debt to Equity History and Analysis
Debt Level: 603367 has more cash than its total debt.
Reducing Debt: 603367's debt to equity ratio has increased from 0% to 3.3% over the past 5 years.
Debt Coverage: 603367's debt is well covered by operating cash flow (306.2%).
Interest Coverage: 603367 earns more interest than it pays, so coverage of interest payments is not a concern.